Medrad Stellant CT Injector System with Imaging System Interface Module
by Medrad, Inc.
510(k) K033881
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK033881 | Date2 Mar 2004 | StatusActive |
Recalls
-
- Terminated Z-0154-06
the heat maintainer, an accessory, may overheat and deform the disposable syringe
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXT
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1650
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 20 Sep 2026
The Medrad Stellant CT Injector System is a syringe-based fluid delivery device classified as an Injector and Syringe, Angiographic. It is designed to administer intravenous contrast media during computed tomography (CT) imaging procedures. The system ensures precise and controlled injection of contrast agents to enhance diagnostic imaging quality in cardiovascular and other CT applications.
This device is intended for single-patient use and includes an optional Imaging System Interface (ISI) module for compatibility with CT scanners. Supplied as a reusable system, it requires proper sterilization and maintenance per manufacturer guidelines. The device holds FDA 510K clearance under classification DXT (Device Class 2) and is regulated under 21 CFR 870.1650. No MRI safety information is specified.
Other devices from Medrad, Inc.
Questions
AI-generated answers, 20 Sep 2026
What is the primary purpose of the Medrad Stellant CT Injector System, and how does it improve CT imaging procedures?
The Medrad Stellant CT Injector System is designed to administer intravenous contrast media during computed tomography (CT) imaging, specifically for cardiovascular and other CT applications. It ensures precise and controlled injection of contrast agents, which enhances the clarity and diagnostic quality of the images by improving the visibility of blood vessels and tissues.
Is the Medrad Stellant CT Injector System intended for single-use or reusable applications, and what are the maintenance requirements?
The Medrad Stellant CT Injector System is intended for single-patient use, meaning each system is meant to be used once per patient. However, the core reusable components of the system require proper sterilization and maintenance as outlined in the manufacturer’s guidelines to ensure safe and effective reuse across multiple procedures.
Does this device include any compatibility features for integration with CT scanners, and if so, what is their purpose?
Yes, the Medrad Stellant CT Injector System includes an optional Imaging System Interface (ISI) module, which enables compatibility with CT scanners. This module facilitates seamless integration between the injector and imaging systems, allowing for synchronized contrast media delivery and optimized imaging workflows.
How is the regulatory status of this device determined, and what classification does it fall under?
The Medrad Stellant CT Injector System holds FDA 510K clearance, meaning it has been determined to be substantially equivalent to a legally marketed device. It is classified under Device Class 2 (DXT) and regulated under 21 CFR 870.1650, reflecting its role as an injector and syringe for angiographic applications.
Are there any specific storage or handling instructions for this device beyond standard medical equipment protocols?
While the provided data does not specify detailed storage instructions beyond general medical equipment protocols, the reusable components of the Medrad Stellant CT Injector System require adherence to the manufacturer’s sterilization and maintenance guidelines to ensure functionality and safety. Proper handling and storage are critical to prevent contamination and maintain performance.